GSDMD and rheumatoid arthritis: RA is known to be driven by TNF, and it was recently shown that mice lacking the pyroptosis executor GSDMD are protected against a model of TNF-induced shock [191,211], highlighting GSDMD as a possible therapeutical candidate in RA.